期刊文献+

阻断B7/CD28共刺激通路抑制大鼠肝移植急性排斥反应的研究 被引量:1

Preventing acute rejection after liver transplantation via blockading B7/CD28 costimulatory pathway in rats
在线阅读 下载PDF
导出
摘要 目的:建立大鼠原位肝移植(ROLT)急性排斥反应模型,观察细胞毒淋巴细胞抗原4免疫球蛋白(CTLA-4Ig)在大鼠肝移植术后对共刺激分子B7-1/B7-2的影响及其抗排斥反应的作用。方法:采用"二袖套管"法先行建立DA-Lewis大鼠组合肝移植急性排斥反应模型,随机分为对照组(A组)与实验组(B组)两组,于肝移植术后48h每只受体大鼠腹腔内一次性注射CTLA-4Ig 75μg,分别于术后3、5、7和10d采用RT-PCR检测B7-1和B7-2 mRNA在两组肝脏组织中的表达情况,并同时观察其肝功能变化。结果:1)B7-1和B7-2 mRNA在A组高水平表达,而在B组表达明显降低(P<0.01);2)B组动物术后未见明显排斥反应,血清ALT、TBIL和DBIL水平明显低于对照组(P<0.01)。结论:移植术后应用CTLA-4Ig可以降低肝组织中B7-1和B7-2的表达;动态检测B7分子的表达有助于观察肝移植排斥反应的进程。 Objective: To observe the effect of CTLA-4lg on preventing acute rejection and the role of costimulatory molecule B7-1 and B7-2 via the model of orthotopic liver transplantation (ROLT) in rats. Methods:Build the model of ROLT (DA- Lewis,). All rats were divided into 2 groups randomly.Group A was control group. Group B was injected with CTLA4-lg into abdominal cavity after 48 hours of operation. Animals were sacrificed on the day 3,5,7,10 after ROLT to detect the changes of serum biochemistry (ALT, TBIL and DBIL).Liver grafts were collected for measuring the expression of B7-1 and B7-2 mRNA by RT-PCR.Results:1)Compared with the control group, the expression of B7-1 and B7-2 mRNA increased significantly(P〈 0.01). 2)In group B, no clinical rejection character were obserbed and serum biochemistry was lower than cortol group (P〈0.01). Conclusion: CTLA-4lg treatment can abate the expression of B7-1 and B7-2 mRNA. The dynami determination of costimulatory molecule B7 is helpful to the observation of rejection course in rats.
出处 《中国现代普通外科进展》 CAS 2007年第5期382-385,共4页 Chinese Journal of Current Advances in General Surgery
基金 教育部博士点基金(20050422058) 山东省自然科学基金资助项目(Y2003c15)
关键词 细胞毒淋巴细胞抗原4免疫球蛋白·共刺激分子·肝移植·排斥反应 Cytotoxic T lymphocyte antigen-4 immunoglobulin G· Costimulatory molecule·Liver transplantation · Rejection
作者简介 刘钊(1975.11-),山东济南人,硕士,济南市中心医院主治医师,研究方向:肝胆外科。Tel:13805311761 E—mail:Lzconquer@yahoo.com.cn [通讯作者]徐克森,山东大学齐鲁医院普外科,教授。Tel:13969059666
  • 相关文献

参考文献10

  • 1Bretscher P. Thetwo-signal model of lymphocyte activation twenty-one years later[J]. Immunol Today, 1992,13(2):74.
  • 2Sayegh MH. Finally, CTLA4Ig graduates to the clinic[J].J Clin Invest, 1999, 103(9):1223-1225.
  • 3Kojima N, Sato M, Suzuki A, et al. Enhanced expression of B7-1, B7-2, and intercellular adhesion molecule 1 in sinusoidal endothelial cells by warm ischemia/reperfusion injury in rat liver[J]. Hepatology, 2001,34(4):751-757.
  • 4Lafferty KJ. A few steps along the path to adult transplantation tolerance[J]. Transplant Proc, 1999,31 (1-2A): 11S.
  • 5纪志鹏,徐克森.共刺激分子CD28/B7家族在抑制肝脏移植排斥反应中的研究现状及展望[J].中国现代普通外科进展,2005,8(5):260-262. 被引量:6
  • 6Carreno BM, Collins M. The B7 family of ligands and its receptors: new pathways for cost imulation and inhibition of immune response [J]. Annu Rev Immunol, 2002,20:29-53.
  • 7Sharpe AH, Freeman GJ. The B7-CD28 superfamily[J]. Nat Rev Immunol, 2002,2(2):116-126.
  • 8Ogawa S, Nitta K, Hara Y, et al. CD28 knockout mice as a useful clue to examine the pathogenesis of chronic graft-versus-host reaction[J]. Kidney International, 2000,58(5): 2215-2220.
  • 9Galvin F, Freeman G J, Razi-wolf Z, et al. Murine B7 antigen providesAsufficient costimulatory signal for antigen_specific and MHC-restricted T cell activation[J].J Immunol, 1992,149(12)3802-3808.
  • 10Neumann UP, Fischer U, Schmitz V, et al. Long-term graft acceptance after rat liver allograft transplantation induced by application of CTLA4-Ig anddonor specific spleen cell administration [J]. Transplant Proc, 2002,34(5):1400-1401.

二级参考文献28

  • 1Carreno B M,Collins M .The B7 family of ligands and its receptors:new pathways for costimulation and inhibition of immune response[J].Annu Rev Immunol,2002,20:29-53.
  • 2Sharpe A H,Freeman G J.The B7-CD28 superfamily[J].Nat Rev Immunol,2002,2:116-126.
  • 3Shengdian Wang,Liping Chen.Co-signaling molecules of the B7-CD28 family in positive and negative regulation of T lymphocyte response[J].Microbes Infec,2004,6759-6766.
  • 4Dong H,Zhu G,Tamada K,et al.B7-H1,a third member of the B7 family,co-stimulates T-cell proliferation and interleukin-10 secretion[J].Nat Med,1999,5:1365-1369.
  • 5Freeman GL,Long AL,Y Iwai,et al.Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation[J].J Exp Med,2000,192:1027-1034.
  • 6Tseng S Y,Otsuji M,Gorski K,et al.B7-DC,a new dentriticcell molecule with potent costimulatory properties for T cells[J].J Exp Med,2001,193:839-846.
  • 7Latchman Y,Wood C R,Chernove T,et al.PD-L2,a novel B7 homologue,is a second ligand for PD-1 and inhibits T cell activation[J].Nat Immunol,2001,2:261-268.
  • 8Wang S,Bajorath J,Files D B,et al.Molecular modeling and functional mapping of B7-H1 and B7-DC delineate independent binding structures for PD-1 and a costimulatory receptor[J].J Exp Med,2003,197:1083-1091.
  • 9Wang S,Zhu G,Chapoval AI,et al.Costimulation of T cells by B7-H2,a B7-like molecule that binds ICOS[J].Blood,2000,96:2808-2813.
  • 10Hutloff A,Dittrich AM,Beier KC,et al.ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28[J].Nature,1999,397:263-266.

共引文献5

同被引文献1

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部